NC
TMO icon

nVerses Capital’s Thermo Fisher Scientific TMO Stock Holding History

nVerses Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-500
Closed -$277K – 1386
2024
Q2 		$277K Buy
+500
New +$286K 0.17% 203

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

nVerses Capital's TMO Position: Q3 2024 in Review

nVerses Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 500 shares — an estimated $277K sold.

nVerses Capital first reported a position in TMO in Q2 2024 and held it in 1 quarter. The position peaked at $277K in Q2 2024. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • nVerses Capital reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
  • nVerses Capital sold 500 Thermo Fisher Scientific shares in Q3 2024, an estimated $277K.
  • nVerses Capital first reported a position in Thermo Fisher Scientific in Q2 2024 and held it in 1 quarter.
  • nVerses Capital's Thermo Fisher Scientific position peaked at $277K in Q2 2024.
  • 2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.